Agar-Iodine Transdermal Patches for Infected Diabetic Wounds

Area of Science:

• Biomaterials Science
• Wound Healing Research
• Infectious Disease Treatment

Background:

• Diabetic wounds are prone to infection, complicating healing.
• Novel drug delivery systems are needed for effective wound management.
• Iodine-based formulations have antimicrobial properties.

Purpose of the Study:

• To evaluate the efficacy of iodine-loaded agar transdermal patches (AKIG) for treating infected diabetic wounds.
• To compare the performance of AKIG patches against commercial wound dressings.
• To assess the antimicrobial activity and physical properties of the AKIG patch.

Main Methods:

• Wistar rat model of infected diabetic wounds.
• Treatment with agar-iodine-potassium iodide-glycerol (AKIG) patches, Iodoflex, and Tegaderm.
• Antimicrobial testing against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.
• Evaluation of patch physical properties (tensile strength, elongation, WVTR, swelling).

Main Results:

• AKIG patches and Iodoflex demonstrated superior infection containment and complete wound healing compared to Tegaderm.
• Pseudomonas aeruginosa showed the highest resistance (MIC/MBC) to all tested patches.
• The AKIG patch exhibited favorable physical properties and followed first-order iodine release kinetics.

Conclusions:

• Agar-iodine-potassium iodide (KI) transdermal patches are effective in managing infected diabetic wounds.
• The developed AKIG patch offers a promising alternative to existing wound care treatments.
• Further research into transdermal patch technology for wound healing is warranted.